Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Effects of and Exploring the Processes of Free Movement Dance as a Physical Therapy Intervention for Female Patients Diagnosed With Chronic Widespread Pain (Including Fibromyalgia). 03/16/2022 INTERVENTIONAL unchanged 1,624.85 0 Improving Diagnostics in Cervical Dysplasia 03/17/2022 INTERVENTIONAL unchanged 1,623.85 0 The National Lipedema Study 03/17/2022 INTERVENTIONAL unchanged 1,623.85 0 Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer 03/17/2022 INTERVENTIONAL unchanged 1,623.85 0 Limited Ankle Dorsiflexion and Effect on Single Limb Squats in Individuals With Patellofemoral Pain 03/17/2022 INTERVENTIONAL unchanged 1,623.85 0 Mobile Phone Messaging to Improve Reproductive Health for Women Living With HIV in Kenya (Mobile WACh Empower) 03/17/2022 INTERVENTIONAL unchanged 1,623.85 0 Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants 03/18/2022 OBSERVATIONAL unchanged 1,622.85 0 Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme 03/18/2022 INTERVENTIONAL unchanged 1,622.85 0 The Efficacy of Aspirin Combined With Hydroxychloroquine Treatment in High Risk Pregnancies for Preeclampsia 03/18/2022 INTERVENTIONAL unchanged 1,622.85 0 Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study 03/18/2022 INTERVENTIONAL unchanged 1,622.85 0 Oxytocin Maintenance Infusion in Labouring Women Undergoing Cesarean Delivery: an Up-down Sequential Allocation Study 03/22/2022 INTERVENTIONAL unchanged 1,618.85 0 Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System 03/22/2022 INTERVENTIONAL unchanged 1,618.85 0 Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer 03/23/2022 INTERVENTIONAL unchanged 1,617.85 0 Belgian Study to Assess the Efficacy and Safety of the RESTORER Iliac Stent for Treatment of Aorto-iliac Lesions. 03/23/2022 INTERVENTIONAL unchanged 1,617.85 0 Smart Bra for Diagnosing Breast Cancer 03/24/2022 INTERVENTIONAL unchanged 1,616.85 0 Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer 03/25/2022 INTERVENTIONAL unchanged 1,615.85 0 Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk 03/28/2022 INTERVENTIONAL unchanged 1,612.85 0 Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women 03/28/2022 INTERVENTIONAL unchanged 1,612.85 0 Healthy Eating in Women at Risk of Gestational Diabetes 03/29/2022 INTERVENTIONAL unchanged 1,611.85 0 Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal) 03/29/2022 OBSERVATIONAL unchanged 1,611.85 0 A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection 03/29/2022 INTERVENTIONAL unchanged 1,611.85 0 LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women 03/31/2022 INTERVENTIONAL unchanged 1,609.85 0 IV Iron Trial for Anemia Related to Uterine Bleeding in Female Patients Presenting to the Emergency Department 03/31/2022 INTERVENTIONAL unchanged 1,609.85 0 Assessment of Brain Cognitive Impairment in Breast Cancer 03/31/2022 OBSERVATIONAL unchanged 1,609.85 0 Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study 04/04/2022 INTERVENTIONAL unchanged 1,605.85 0 Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial 04/04/2022 INTERVENTIONAL unchanged 1,605.85 0 Cardiac Outcomes With Near-Complete Estrogen Deprivation 04/04/2022 INTERVENTIONAL unchanged 1,605.85 0 Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal) 04/04/2022 OBSERVATIONAL unchanged 1,605.85 0 Niche In CEsarean Scar Trial (NICEST) 04/06/2022 INTERVENTIONAL unchanged 1,603.85 0 Selective Omission of Axillary Surgery in Triple-negative and HER2-positive Breast Cancer After NACT 04/06/2022 INTERVENTIONAL unchanged 1,603.85 0 Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer 04/07/2022 INTERVENTIONAL unchanged 1,602.85 0 Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer 04/07/2022 INTERVENTIONAL unchanged 1,602.85 0 CRS & HIPEC for Platinum-Resistant Recurrent Ovarian Cancer (KOV-02R, RECOVER) 04/07/2022 INTERVENTIONAL unchanged 1,602.85 0 A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction 04/07/2022 INTERVENTIONAL unchanged 1,602.85 0 Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia 04/07/2022 INTERVENTIONAL unchanged 1,602.85 0 Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease 04/07/2022 OBSERVATIONAL unchanged 1,602.85 0 GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients 04/07/2022 INTERVENTIONAL unchanged 1,602.85 0 Developing Breast (Cancer) Organoids 04/07/2022 OBSERVATIONAL unchanged 1,602.85 0 Continuous Glucose Monitor Use in Pregnancy 04/08/2022 INTERVENTIONAL unchanged 1,601.85 0 Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. 04/08/2022 INTERVENTIONAL unchanged 1,601.85 0 Web-based Intervention for Long-term Breast Cancer Survivors 04/11/2022 INTERVENTIONAL unchanged 1,598.85 0 Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women 04/12/2022 INTERVENTIONAL unchanged 1,597.85 0 Genetic Counseling Patient Preference Intervention Versus Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer 04/13/2022 INTERVENTIONAL unchanged 1,596.85 0 1 Versus 2 Hours Post Meal Glucose Monitoring in Gestational Diabetes on Treatment 04/13/2022 OBSERVATIONAL unchanged 1,596.85 0 Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients 04/13/2022 OBSERVATIONAL unchanged 1,596.85 0 Investigation of Copy Number Variations and Genetic Variants in POI 04/14/2022 OBSERVATIONAL unchanged 1,595.85 0 Effects of Online Yoga on the Quality of Life of Breast Cancer Patients 04/14/2022 INTERVENTIONAL unchanged 1,595.85 0 Use of GnRHa During Chemotherapy for Fertility Protection 04/14/2022 INTERVENTIONAL unchanged 1,595.85 0 Cumulus Cell Mitochondrial Activity as a Non-invasive Marker of Embryo Quality (FLIM) 04/18/2022 OBSERVATIONAL unchanged 1,591.85 0 OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk 04/18/2022 INTERVENTIONAL unchanged 1,591.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology